Oragenics gets NYSE American deficiency notice, updates trial and FDA progressAug 28Clinical readoutOragenics, Inc.
Oragenics appoints John Spencer as CFO, holds annual meeting with mixed votesJul 6PartnershipOragenics, Inc.
Sign in